# Divergent roles of circMPP6 and its parental gene MPP6 in non-small cell lung cancer

**Authors:** Weijuan Gao, Feng Pan, Kangping Qiu, Canhui Ou, Fang Tian, Chengtao Yu

PMC · DOI: 10.3389/fcell.2026.1722916 · Frontiers in Cell and Developmental Biology · 2026-02-03

## TL;DR

This study shows that circMPP6 and its parental gene MPP6 have opposite effects on non-small cell lung cancer growth, with circMPP6 counteracting tumor promotion.

## Contribution

Reveals divergent roles of circMPP6 and MPP6 in NSCLC, including opposing effects on proliferation and hypoxia signaling.

## Key findings

- circMPP6 and MPP6 regulate distinct gene sets and chromosomal regions in NSCLC.
- circMPP6 reduces lactate and glutathione, while MPP6 increases glutathione and promotes proliferation.
- circMPP6 downregulates SLC7A11, whereas MPP6 upregulates it, with both linked to hypoxia signaling.

## Abstract

Circular RNAs (circRNAs) regulate cancer biology, but their relationships with parental genes remain unclear. We characterized circMPP6, derived from MPP6, and its interplay with MPP6 in non-small cell lung cancer (NSCLC).

circMPP6 was validated by RNase R resistance and Sanger sequencing in A549 cells. Expression of circMPP6 and MPP6 was measured in 10 paired NSCLC tumors and adjacent-tissues. RNA-seq after gain-of-function of circMPP6, MPP6, and SLC7A11 was followed by enrichment analyses and chromosome-level DEG mapping. Proliferation was assessed by CCK-8 and xenografts. Lactate and glutathione were quantified, SLC7A11 protein measured by Western blot, and prognosis analyzed in GEO/TCGA.

MPP6 trended upward in tumors, while circMPP6 was unchanged. circMPP6 and MPP6 were positively correlated in adjacent-tissues but not in tumors. Overexpression of circMPP6 and MPP6 yielded 765 and 334 DEGs, respectively, with shared enrichment of hypoxia-related pathways. 67 genes were upregulated by circMPP6 but downregulated by MPP6, also linked to hypoxia signaling. circMPP6-regulated DEGs were enriched on chromosome 19, whereas MPP6-regulated DEGs clustered on chromosome 17. Functionally, circMPP6 did not alter proliferation, MPP6 enhanced it, and co-expression attenuated MPP6-driven growth in vitro and in vivo. circMPP6 reduced intracellular lactate and glutathione; MPP6 minimally affected lactate and increased glutathione. Consistently, circMPP6 downregulated SLC7A11, whereas MPP6 upregulated it. High-risk circMPP6-driven signatures and high MPP6 expression associated with poorer prognosis.

circMPP6 and MPP6 exert distinct, partially opposing effects on NSCLC growth. In the context of MPP6 overexpression, circMPP6 counteracts tumor-promoting programs, highlighting functional divergence between circRNAs and their parental genes.

## Linked entities

- **Genes:** MPHOSPH6 (M-phase phosphoprotein 6) [NCBI Gene 10200], SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657]
- **Proteins:** SLC7A11 (solute carrier family 7 member 11)
- **Chemicals:** lactate (PubChem CID 61503), glutathione (PubChem CID 124886)
- **Diseases:** non-small cell lung cancer (MONDO:0005233), NSCLC (MONDO:0005233)

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, IGF2 (insulin like growth factor 2) [NCBI Gene 3481] {aka C11orf43, GRDF, IGF-II, PP9974, SRS3}, Slc7a11 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 11) [NCBI Gene 26570] {aka 9930009M05Rik, sut, xCT}, MIR936 (microRNA 936) [NCBI Gene 100126326] {aka MIRN936, hsa-mir-936}, PALS2 (protein associated with LIN7 2, MAGUK p55 family member) [NCBI Gene 51678] {aka MPP6, VAM-1, VAM1, p55T}, FSCN1 (fascin actin-bundling protein 1) [NCBI Gene 6624] {aka HSN, SNL, p55}, Pals2 (protein associated with LIN7 2, MAGUK family member) [NCBI Gene 56524] {aka Mpp6, P55t}, STC2 (stanniocalcin 2) [NCBI Gene 8614] {aka STC-2, STCRP}, DDIT4 (DNA damage inducible transcript 4) [NCBI Gene 54541] {aka Dig2, REDD-1, REDD1}, TRIM25 (tripartite motif containing 25) [NCBI Gene 7706] {aka EFP, RNF147, Z147, ZNF147}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, AGO2 (argonaute RISC catalytic component 2) [NCBI Gene 27161] {aka CASC7, EIF2C2, LESKRES, LINC00980, PPD, Q10}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, FBXW7 (F-box and WD repeat domain containing 7) [NCBI Gene 55294] {aka AGO, CDC4, DEDHIL, FBW6, FBW7, FBX30}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, IGF2BP1 (insulin like growth factor 2 mRNA binding protein 1) [NCBI Gene 10642] {aka CRD-BP, CRDBP, IMP-1, IMP1, VICKZ1, ZBP1}, MPHOSPH6 (M-phase phosphoprotein 6) [NCBI Gene 10200] {aka MPP, MPP-6, MPP6}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, NDRG1 (N-myc downstream regulated 1) [NCBI Gene 10397] {aka CAP43, CMT4D, DRG-1, DRG1, GC4, HMSNL}, HIPK3 (homeodomain interacting protein kinase 3) [NCBI Gene 10114] {aka DYRK6, FIST3, PKY, YAK1}, MIR623 (microRNA 623) [NCBI Gene 693208] {aka MIRN623, hsa-mir-623}, MIR326 (microRNA 326) [NCBI Gene 442900] {aka MIRN326, hsa-mir-326, mir-326}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, ITCH (itchy E3 ubiquitin protein ligase) [NCBI Gene 83737] {aka ADMFD, AIF4, AIP4, NAPP1}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, Vcl (vinculin) [NCBI Gene 22330] {aka 9430097D22}, MIR188 (microRNA 188) [NCBI Gene 406964] {aka MIRN188, miR-188}, MIR1305 (microRNA 1305) [NCBI Gene 100302270] {aka MIRN1305, hsa-mir-1305, mir-1305}, MIR649 (microRNA 649) [NCBI Gene 693234] {aka MIRN649, hsa-mir-649}, ATF4 (activating transcription factor 4) [NCBI Gene 468] {aka CREB-2, CREB2, TAXREB67, TXREB}, ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, ANGPTL4 (angiopoietin like 4) [NCBI Gene 51129] {aka ARP4, FIAF, HARP, HFARP, NL2, PGAR}
- **Diseases:** NSCLC (MESH:D002289), hypoxia (MESH:D000860), PA (MESH:C537238), LUAD (MESH:D000077192), tumorigenesis (MESH:D063646), Lung cancer (MESH:D008175), Cancer (MESH:D009369), prostate cancer (MESH:D011471), colorectal cancer (MESH:D015179)
- **Chemicals:** SDS (MESH:D012967), water (MESH:D014867), CCK-8 (MESH:D012844), TRIzol (MESH:C411644), L-Lactate (MESH:D019344), streptomycin (MESH:D013307), PBS (MESH:D007854), PVDF (MESH:C024865), CoCl2 (MESH:C018021), poly(A) (MESH:D011061), SYBR Green (MESH:C098022), GSH (MESH:D005978), CO2 (MESH:D002245), agarose (MESH:D012685), DMEM (-), cystine (MESH:D003553), penicillin (MESH:D010406)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** H1975 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_1511), H1299 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0060), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), HCC827 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_2063)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960637/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960637/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960637/full.md

---
Source: https://tomesphere.com/paper/PMC12960637